Technetium-labeled erythrocyte scintigraphy in acute gastrointestinal bleeding

Area of Science:

• Nuclear Medicine
• Gastroenterology
• Diagnostic Imaging

Background:

• Accurate localization of acute gastrointestinal (GI) bleeding is crucial for effective patient management.
• The utility of technetium-labeled erythrocyte scintigraphy (TRBC scan) in diagnosing acute GI bleeding remains debated.
• Recent literature suggests TRBC scans may serve as a reliable first-line diagnostic tool.

Purpose of the Study:

• To evaluate the clinical outcomes and diagnostic performance of TRBC scans in patients with acute GI bleeding.
• To assess the accuracy of TRBC scans in identifying the source of acute GI hemorrhage.
• To determine the effectiveness of TRBC scans in guiding clinical decisions for acute GI bleeding.

Main Methods:

• Retrospective analysis of 80 consecutive TRBC scans performed for acute GI bleeding.
• Exclusion of scans for occult bleeding or performed more than 48 hours after admission.
• Review of patient medical records to correlate scan results with confirmed bleeding sources.

Main Results:

• Out of 80 scans, 29 (36%) were positive and 51 (64%) were negative for bleeding.
• The scan demonstrated a high rate of incorrect positives (10%) and false negatives (21%).
• In cases where the bleeding source was confirmed (31 patients), TRBC scans had a true positive rate of 39% and a false negative rate of 55%.

Conclusions:

• TRBC scans exhibit a low positive yield with significant rates of incorrect positive and false negative findings in acute GI bleeding.
• Current data indicate that TRBC scans may not be a reliable first-line diagnostic test for acute GI bleeding.
• Further investigation is required to enhance TRBC scan techniques, optimize patient selection, and define its specific clinical applications.